191 related articles for article (PubMed ID: 25992239)
1. Dormancy of growth-stunted malignant melanoma: sustainable and smoldering patterns.
Piérard-Franchimont C; Hermanns-Lê T; Delvenne P; Piérard GE
Oncol Rev; 2014 Sep; 8(2):252. PubMed ID: 25992239
[TBL] [Abstract][Full Text] [Related]
2. Smouldering malignant melanoma and metastatic dormancy: an update and review.
Piérard GE; Piérard-Franchimont C; Reginster MA; Quatresooz P
Dermatol Res Pract; 2012; 2012():461278. PubMed ID: 22110487
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
4. Malignant melanoma and its stromal nonimmune microecosystem.
Piérard GE; Piérard-Franchimont C; Delvenne P
J Oncol; 2012; 2012():584219. PubMed ID: 22811710
[TBL] [Abstract][Full Text] [Related]
5. Cancer Metastases: Early Dissemination and Late Recurrences.
Friberg S; Nyström A
Cancer Growth Metastasis; 2015; 8():43-9. PubMed ID: 26640389
[TBL] [Abstract][Full Text] [Related]
6. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
Schlag PM
Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
[TBL] [Abstract][Full Text] [Related]
7. Cell proliferation in cutaneous malignant melanoma: relationship with neoplastic progression.
Piérard GE
ISRN Dermatol; 2012; 2012():828146. PubMed ID: 22363864
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma.
Barnhill RL; Fandrey K; Levy MA; Mihm MC; Hyman B
Lab Invest; 1992 Sep; 67(3):331-7. PubMed ID: 1383607
[TBL] [Abstract][Full Text] [Related]
9. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
Su BB; Zhou SW; Gan CB; Zhang XN
J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
[TBL] [Abstract][Full Text] [Related]
10. Clinical and histologic features of level 2 cutaneous malignant melanoma associated with metastasis.
Taran JM; Heenan PJ
Cancer; 2001 May; 91(9):1822-5. PubMed ID: 11335909
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
12. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.
Bergman PJ; McKnight J; Novosad A; Charney S; Farrelly J; Craft D; Wulderk M; Jeffers Y; Sadelain M; Hohenhaus AE; Segal N; Gregor P; Engelhorn M; Riviere I; Houghton AN; Wolchok JD
Clin Cancer Res; 2003 Apr; 9(4):1284-90. PubMed ID: 12684396
[TBL] [Abstract][Full Text] [Related]
14. Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.
Hussein MR; Elsers DA; Fadel SA; Omar AE
J Clin Pathol; 2006 Mar; 59(3):316-24. PubMed ID: 16505286
[TBL] [Abstract][Full Text] [Related]
15. [Expression of neutral endopeptidase and motility-related protein-1 in cutaneous malignant melanoma].
Wu Y; Zhang XB; Liu HJ; Zheng LD; Li JW; Lin Y
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):466-9. PubMed ID: 17845760
[TBL] [Abstract][Full Text] [Related]
16. Sister chromatid exchange and proliferation pattern in stimulated lymphocytes of cutaneous malignant melanoma patients.
Privitera E; Ghidoni A; Raimondi E; Rovini D; Illeni MT; Cascinelli N
Cancer Genet Cytogenet; 1985 Feb; 15(1-2):37-45. PubMed ID: 3967218
[TBL] [Abstract][Full Text] [Related]
17. The impact of surgery on the course of melanoma.
Lejeune FJ
Recent Results Cancer Res; 2002; 160():151-7. PubMed ID: 12079209
[TBL] [Abstract][Full Text] [Related]
18. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain.
Ródenas JM; Delgado-Rodríguez M; Farinas-Alvarez C; Herranz MT; Serrano S
Am J Epidemiol; 1997 Jun; 145(11):1020-9. PubMed ID: 9169911
[TBL] [Abstract][Full Text] [Related]
19. Assessment of proliferation markers in metastatic melanoma in sentinel lymph nodes.
Joannou-Coetzee A; Villena N; Powell BW; Cook MG
J Clin Pathol; 2011 Dec; 64(12):1108-11. PubMed ID: 21896579
[TBL] [Abstract][Full Text] [Related]
20. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma.
Eyles J; Puaux AL; Wang X; Toh B; Prakash C; Hong M; Tan TG; Zheng L; Ong LC; Jin Y; Kato M; Prévost-Blondel A; Chow P; Yang H; Abastado JP
J Clin Invest; 2010 Jun; 120(6):2030-9. PubMed ID: 20501944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
